Quarterly report pursuant to Section 13 or 15(d)

Condensed Consolidated Statements of Changes in Shareholders??? Deficit (Unaudited)

v3.22.2.2
Condensed Consolidated Statements of Changes in Shareholders’ Deficit (Unaudited) - USD ($)
Common Stock
Additional Paid-in Capital
Accumulated Deficit
Noncontrolling Interest
Total
Balance at Dec. 31, 2020 $ 228,347 $ 42,573,272 $ (45,968,839) $ (3,167,220)
Balance (in Shares) at Dec. 31, 2020 228,346,974        
Common stock issued for professional fees $ 1,550 112,550 114,100
Common stock issued for professional fees (in Shares) 1,550,000        
Common stock issued for compensation $ 2,700 (2,700)
Common stock issued for compensation (in Shares) 2,700,000        
Common stock issued for accrued compensation $ 945 54,796 55,741
Common stock issued for accrued compensation (in Shares) 944,767        
Common stock issued for cashless warrant exercise $ 1,008 (1,008)
Common stock issued for cashless warrant exercise (in Shares) 1,008,000        
Preferred stock dividends and deemed dividend 2,845,238 (2,855,576) (10,338)
Accretion of stock-based compensation 108,554 108,554
Accretion of stock-based professional fees 5,000 5,000
Beneficial conversion charge for issuance of Series B preferred shares for accrued compensation recorded as stock-based compensation 3,778,810 3,778,810
Net loss (4,863,973) (4,863,973)
Balance at Mar. 31, 2021 $ 234,550 49,474,512 (53,688,388) (3,979,326)
Balance (in Shares) at Mar. 31, 2021 234,549,741        
Balance at Dec. 31, 2020 $ 228,347 42,573,272 (45,968,839) (3,167,220)
Balance (in Shares) at Dec. 31, 2020 228,346,974        
Net loss         (5,442,998)
Balance at Jun. 30, 2021 $ 241,051 49,778,041 (54,278,891) (4,259,799)
Balance (in Shares) at Jun. 30, 2021 241,050,965        
Balance at Mar. 31, 2021 $ 234,550 49,474,512 (53,688,388) (3,979,326)
Balance (in Shares) at Mar. 31, 2021 234,549,741        
Common stock issued for professional fees $ 2,700 138,300 141,000
Common stock issued for professional fees (in Shares) 2,700,000        
Common stock issued for accounts payable $ 3,801 114,037 117,838
Common stock issued for accounts payable (in Shares) 3,801,224        
Preferred stock dividends and deemed dividend (11,478) (11,478)
Accretion of stock-based compensation 51,192 51,192
Net loss (579,025) (579,025)
Balance at Jun. 30, 2021 $ 241,051 49,778,041 (54,278,891) (4,259,799)
Balance (in Shares) at Jun. 30, 2021 241,050,965        
Balance at Dec. 31, 2021 $ 282,217 53,064,616 (57,515,129) 189,255 (3,979,041)
Balance (in Shares) at Dec. 31, 2021 282,216,632        
Common stock issued for accounts payable $ 90 2,084 2,174
Common stock issued for accounts payable (in Shares) 90,859        
Common stock issued for compensation $ 500 13,750 14,250
Common stock issued for compensation (in Shares) 500,000        
Common stock issued for conversion of Series C preferred stock $ 1,543 10,457 12,000
Common stock issued for conversion of Series C preferred stock (in Shares) 1,543,151        
Common stock issued in connection with debt $ 824 12,139 12,963
Common stock issued in connection with debt (in Shares) 823,529        
Preferred stock dividends and deemed dividend (14,005) (14,005)
Accretion of stock-based compensation 42,702 42,702
Beneficial conversion charge for issuance of Series B preferred shares for accrued compensation recorded as stock-based compensation 957,556 957,556
Net loss (1,906,399) (13,020) (1,919,419)
Balance at Mar. 31, 2022 $ 285,174 54,103,304 (59,435,533) 176,235 (4,870,820)
Balance (in Shares) at Mar. 31, 2022 285,174,171        
Balance at Dec. 31, 2021 $ 282,217 53,064,616 (57,515,129) 189,255 (3,979,041)
Balance (in Shares) at Dec. 31, 2021 282,216,632        
Net loss         (2,928,771)
Balance at Jun. 30, 2022 $ 307,109 54,963,116 (60,452,441) 166,169 (5,016,047)
Balance (in Shares) at Jun. 30, 2022 307,108,719        
Balance at Mar. 31, 2022 $ 285,174 54,103,304 (59,435,533) 176,235 (4,870,820)
Balance (in Shares) at Mar. 31, 2022 285,174,171        
Common stock issued for professional fees $ 7,000 95,000 102,000
Common stock issued for professional fees (in Shares) 7,000,000        
Relative fair value of warrants issued in connection with debt 325,785 325,785
Beneficial conversion feature on convertible debt 469,899 469,899
Beneficial conversion feature buyback related to debt extinguishment (160,993) (160,993)
Common stock issued for conversion of Series C preferred stock $ 13,185 88,815 102,000
Common stock issued for conversion of Series C preferred stock (in Shares) 13,184,548        
Common stock issued in connection with debt $ 1,750 30,986 32,736
Common stock issued in connection with debt (in Shares) 1,750,000        
Preferred stock dividends and deemed dividend 3,702 (17,622) (13,920)
Accretion of stock-based compensation 6,618 6,618
Net loss (999,286) (10,066) (1,009,352)
Balance at Jun. 30, 2022 $ 307,109 $ 54,963,116 $ (60,452,441) $ 166,169 $ (5,016,047)
Balance (in Shares) at Jun. 30, 2022 307,108,719